DNA aptamer raised against advanced glycation end products inhibits neointimal hyperplasia in balloon-injured rat carotid arteries

International Journal of Cardiology

Volumn 171, Issue 3, 2014, Pages 443-446

  Ojima, Ayako ^a   Oda, Eriko ^a   Higashimoto, Yuichiro ^a   Matsui, Takanori ^a   Yamagishi, Sho Ichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AGE aptamer; Balloon injury; Neointimal hyperplasia; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT APTAMER; ADVANCED GLYCATION END PRODUCT RECEPTOR; APTAMER; CELL NUCLEUS ANTIGEN; PLATELET DERIVED GROWTH FACTOR BB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON; CAROTID ARTERY INJURY; CELL PROLIFERATION; CONTINUOUS INFUSION; CONTROLLED STUDY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MACROPHAGE MIGRATION; MALE; MORPHOMETRICS; NEOINTIMA; NONHUMAN; OSMOTIC MINIPUMP; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

AGE-APTAMER; BALLOON INJURY; NEOINTIMAL HYPERPLASIA; RAGE;

ANIMALS; APTAMERS, NUCLEOTIDE; CAROTID ARTERY INJURIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPERPLASIA; MALE; NEOINTIMA; RATS; RATS, WISTAR;

EID: 84893673451     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.12.143     Document Type: Article

References (26)

1. H. Vlassara, and R. Bucala Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors Diabetes Suppl. 3 1996 S65 S66
2. S. Rahbar Novel inhibitors of glycation and AGE formation Cell Biochem Biophys 48 2007 147 157
3. S. Yamagishi Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes Exp Gerontol 46 2011 217 224
4. R. Ramasamy, S.F. Yan, and A.M. Schmidt Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications Ann NY Acad Sci 1243 2011 88 102
5. A.D. Ellington, and J.W. Szostak In vitro selection of RNA molecules that bind specific ligands Nature 346 1990 818 822
6. E.S. Gragoudas, A.P. Adamis, E.T. Cunningham, M. Feinsod, and D.R. Guyer Group VISiONCT. Pegaptanib for neovascular age-related macular degeneration N Engl J Med 351 2004 2805 2816
7. P. Jilma-Stohlawetz, J.C. Gilbert, M.E. Gorczyca, P. Knöbl, and B. Jilma A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura Thromb Haemost 106 2011 539 547
8. Y. Kaida, K. Fukami, and T. Matsui et al. DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathy Diabetes 62 2013 3241 3250
9. K. Nakamura, S. Yamagishi, and T. Matsui et al. Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation Am J Pathol 170 2007 2159 2170
10. T. Matsui, Y. Nishino, M. Takeuchi, and S. Yamagishi Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis Pharmacol Res 63 2011 383 388
11. A. Ojima, Y. Ishibashi, and T. Matsui et al. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression Am J Pathol 182 2013 132 141
12. S.P. Karas, E.C. Santoian, and M.B. Gravanis Restenosis following coronary angioplasty Clin Cardiol 14 1991 791 801
13. J.W. Cook, M.R. Malinow, G.L. Moneta, L.M. Taylor, and S.L. Orloff Neointimal hyperplasia in balloon-injured rat cartid arteries: The influence of hyperhomocystemia J Vasc Surg 35 2002 158 165
14. L.M. Berglund, O. Kotova, and P. Osmark et al. NEAT regulates the expression of AIF01 and IRT-1 yin and yang splice variants of neointima formation and atherosclerosis Cardiovasc Res 93 2012 414 423
15. G.A.A. Ferns, and T.Y. Avades The mechanisms of coronary restenosis: insights from experimental models Int J Exp Pathol 81 2000 63 88
16. C.L. Jackson, and K.S. Pettersson Effects of probucol on rat carotid artery responses to balloon catheter injury Atherosclerosis 154 2001 407 414
17. J.Y. Jeremy, and A.C. Thomas Animal models for studying neointima formation Curr Vasc Pharmacol 8 2010 198 219
18. A. Soro-Paavonen, A.M. Watson, and J. Li et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes Diabetes 57 2008 2461 2469
19. S. Yamagishi, and T. Imaizumi Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy Curr Pharm Des 11 2005 2279 2299
20. A. Soro-Paavonen, A.M. Watson, and J. Li et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes Diabetes 57 2008 2461 2469
21. A. Levizki PDGF receptor kinase inhibitors for the treatment of restenosis Cardiovasc Res 65 2005 581 586
22. D.E. Mullins, F. Hamud, R. Reim, and H.R. Davis Inhibition of PDGF receptor binding and PDGF-stimulated biological activity in vitro and of intimal lesion formation in vivo by 2-bromomethyl-5-chlorobenzene sulfonylphthalimide Arterioscler Thromb 14 1994 1047 1055
23. J. Zhang, J. Chen, and J. Yang et al. Resveratrol attenuates oxidative stress induced by balloon injury in the rat carotid artery through actions on the ERK1/2 and NF-kappa B pathway Cell Physiol Biochem 31 2013 230 241
24. J.T. Handa, K.M. Reiser, H. Matsunaga, and L.M. Hjelmeland The advanced glycation endproduct pentosidine induces the expression of PDGF-B in human retinal pigment epithelial cells Exp Eye Res 66 1998 411 419
25. Y. Yamamoto, S. Yamagishi, C.C. Hsu, and H. Yamamoto Advanced glycation endproducts-receptor interactions stimulate the growth of human pancreatic cancer cells through the induction of platelet-derived growth factor-B Biochem Biophys Res Commun 222 1996 700 705
26. Y. Inagaki, S. Yamagishi, T. Okamoto, M. Takeuchi, and S. Amano Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation Diabetologia 46 2003 284 287